SNHG6 and metabolic dysfunction-associated steatotic liver disease: Further studies demonstrated that overexpression of SNHG6 accelerates the malignant transformation from non‐alcoholic fatty liver disease (NAFLD) to HCC in a mouse model induced by a high‐cholesterol diet [75].